Target intelligence / Profile preview

ZFP30 zinc finger protein (ZFP30)

Target
ZFP30
Molecular classification
Transcription factor, KRAB-domain zinc finger protein (KRAB zinc finger protein family), C2H2-type zinc finger protein
01

Overview

ZFP30 zinc finger protein is a member of the KRAB-domain containing zinc finger transcription factors, the largest family of mammalian transcriptional regulators[1][3]. ZFP30 directly binds specific retrotransposon-derived DNA sequences through its zinc finger domains and typically recruits the co-regulator KAP1 (TRIM28) to modulate downstream gene expression. Uniquely, ZFP30 can function as a transcriptional activator in adipogenic contexts, enhancing PPARG2 expression and promoting fat cell differentiation. It binds conserved genomic sites, including decayed LINE1 elements, and has evolved within mammalian lineages to play roles in chromatin regulation and gene network integration. While broadly involved in transcriptional regulation, ZFP30’s specific activity in adipogenesis and potential regulation of transposable elements distinguishes it within the large KRAB-ZFP family[1][2][3]. Clinical associations are emergent but not yet well defined; ongoing research explores its relevance to metabolism, gene regulation, and disease.

Other names
Zinc finger protein 30 homologZFP30KIAA0961ZNF745Zfp-30Zinc finger protein 745ZFP30 zinc finger proteinZFP30_HUMAN (UniProt)
02

Mechanism of action

Modulation of gene expression via chromatin modification. Alteration of adipogenic gene regulatory network via transcriptional enhancer activity.

03

Biological functions

Regulation of transcription by RNA polymerase IIDNA-binding activityPromotion of adipogenesis (fat cell differentiation)Regulation of transposable elements and retrotransposonsChromatin binding and remodeling
04

Disease associations

Potential role in metabolic diseases (due to its confirmed function in adipogenesis)Possible involvement in cancer (KRAB-domain ZFPs are implicated in tumorigenesis and tumor progression through transcriptional regulation)Other (regulation of immune response and cell differentiation, as is common for ZFPs)
05

Safety considerations

Therapeutic targeting of transcription factors is generally challenging due to widespread regulatory roles and potential off-target effects.KRAB-ZFPs can influence multiple genes and repetitive elements, raising risk of global gene regulation disturbances.

Beyond the preview

Go deeper on ZFP30 zinc finger protein (ZFP30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZFP30 zinc finger protein (ZFP30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call